Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Hypertension Diagnostics Inc. (HDII : OTC)
 
 • Company Description   
Hypertension Diagnostics is focused on the development of proprietary cardiovascular profiling technology that analyzes arterial pulse pressure waveform data. HDI has developed two models of it's HDI/PulseWave CardioVascular Profiling Instrument. HDI's first model, the HDI/PulseWave CR-2000, is currently in use by physician scientists for researchpurposes only. The second model, the HDI/PulseWave DO-2020, is intended to assist physicians in screening and diagnosing patients with cardiovascular disease. (PRESS RELEASE)

Number of Employees:

 
 • Price / Volume Information   
Yesterday's Closing Price: $0.01 Daily Weekly Monthly
20 Day Moving Average: 164,621 shares
Shares Outstanding: 213.09 (millions)
Market Capitalization: $1.32 (millions)
Beta: -1.91
52 Week High: $0.02
52 Week Low: $0.01
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -23.46% -16.44%
12 Week -20.51% -14.09%
Year To Date -19.48% -4.63%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
550 Highway 7 East Unit 316
-
Minnesota,MN L4B 3Z4
USA
ph: 404-449-6151
fax: 651-687-0485
None http://www.hypertensiondiagnostics.com
 
 • General Corporate Information   
Officers
Liangjian Peng - Chief Executive Officer
Kenneth W. Brimmer - Chief Executive Officer and Chief Financial Office
Larry Leitner - Director
Alan Stern - Director
Dr. Jay Cohn - Director

Peer Information
- (-)
- (-)
- (-)
- (-)
- (-)
- (-)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED INSTRUMENTS
Sector: Medical
CUSIP: 44914V104
SIC: 3841
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: -
Next Expected EPS Date: -
Share - Related Items
Shares Outstanding: 213.09
Most Recent Split Date: (:1)
Beta: -1.91
Market Capitalization: $1.32 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: -  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: -
Price/Cash Flow: -
Price / Sales: -
EPS Growth
vs. Year Ago Period: -%
vs. Previous Quarter: -%
Sales Growth
vs. Year Ago Period: -%
vs. Previous Quarter: -%
ROE
03/31/22 - -
12/31/21 - -
09/30/21 - -
ROA
03/31/22 - -
12/31/21 - -
09/30/21 - -
Current Ratio
03/31/22 - -
12/31/21 - -
09/30/21 - -
Quick Ratio
03/31/22 - -
12/31/21 - -
09/30/21 - -
Operating Margin
03/31/22 - -
12/31/21 - -
09/30/21 - -
Net Margin
03/31/22 - -
12/31/21 - -
09/30/21 - -
Pre-Tax Margin
03/31/22 - -
12/31/21 - -
09/30/21 - -
Book Value
03/31/22 - -
12/31/21 - -
09/30/21 - -
Inventory Turnover
03/31/22 - -
12/31/21 - -
09/30/21 - -
Debt-to-Equity
03/31/22 - -
12/31/21 - -
09/30/21 - -
Debt-to-Capital
03/31/22 - -
12/31/21 - -
09/30/21 - -
 

Powered by Zacks Investment Research ©